References
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: A Cancer J. Clin. 2014;64:9–29.
- Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, and Matrisian LM. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921.
- Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl. J. Med. 2014;371:1039–49.
- Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, et al. Six hundred fifty consecutive pancreatico-duodenectomies in the 1990s: Pathology, complications, and outcomes. Ann. Surg. 1997;226:248–57; discussion 257–260.
- Boggi U, Amorese G, Vistoli F, Caniglia F, De Lio N, Perrone V, et al. Laparoscopic pancreaticoduodenectomy: A systematic literature review. Surg. Endosc. 2015:29(1):9–23.
- The immunohistochemical expression MTA 1 protein and its prognostic value in pancreatic cancer. Journal of Investigative Surgery In press
- Durczynski A, Strzelczyk J. Portal, but not peripheral, blood D-dimer level may help to differentiate malignant from benign pancreatic tumors. Blood Coagul Fibrinolysis. 2015;26:115–116.
- Stott SL, Hsu CH, Tsukrov DI, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl. Acad Sci. U S A. 2010;107(43):18392–7.
- Balzano G, Capretti G, Callea G, Cantù E, Carle F, Pezzilli R. Overuse of surgery in patients with pancreatic cancer. A nationwide analysis in Italy. HPB (Oxford). 2016;18:470–8.
- Kneuertz PJ, Cunningham SC, Cameron JL, Torrez S, Tapazoglou N, Herman JM, et al. Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. J. Gastrointest Surg. 2011;15:1917–1927.